Intas Pharmaceuticals Ltd v DealStreetAsia Pte Ltd [2017] SGHC 74

Case Details

• Citation: [2017] SGHC 74
• Court: High Court of the Republic of Singapore
• Decision Date: 10 April 2017
• Coram: George Wei J
• Case Number: Originating Summons 734 of 2016; Registrar’s Appeals Nos 362 and 378 of 2016
• Hearing Date(s): 10 February 2017
• Claimants / Plaintiffs: INTAS PHARMACEUTICALS LIMITED
• Respondent / Defendant: DEALSTREETASIA PTE LTD
• Counsel for Claimants: Ang Cheng Hock SC, Lim Jun Rui, Ivan and Ramesh Kumar s/o Ramasamy (Allen & Gledhill LLP)
• Counsel for Respondent: Sim Bock Eng, Sngeeta Rai and Lim Si Wei, Samuel (WongPartnership LLP)
• Practice Areas: Civil Procedure; Disclosure of Documents; Pre-action Disclosure; Norwich Pharmacal Orders

Summary

The judgment in Intas Pharmaceuticals Ltd v DealStreetAsia Pte Ltd [2017] SGHC 74 represents a significant judicial examination of the boundaries of pre-action disclosure within the Singapore legal landscape, particularly concerning the intersection of media confidentiality and the tort of malicious falsehood. The dispute arose following the publication of an article on the Defendant’s financial news website, which alleged that the Plaintiff, a major Indian pharmaceutical firm, was in "early talks" to be acquired by a competitor, Sun Pharmaceuticals Industries Ltd ("SPI"), for a sum potentially reaching $2.3 billion. The Plaintiff vehemently denied these reports, asserting they were "completely base less," and subsequently sought pre-action discovery and interrogatories to identify the sources of the information and to assess the viability of a claim for malicious falsehood.

The High Court, presided over by George Wei J, was tasked with determining whether the Plaintiff had met the stringent "necessity" and "justice" thresholds required under Order 24 Rule 6 and Order 26A Rule 1 of the Rules of Court. The core of the legal tension lay in the Plaintiff’s dual objectives: first, to obtain evidence to evaluate a potential claim against the publisher (the "First Purpose"), and second, to identify the anonymous sources behind the report to facilitate legal action against them (the "Second Purpose"). The latter objective invoked the principles of Norwich Pharmacal relief, which allows for the disclosure of information from a third party who has become "mixed up" in the tortious acts of others.

In a nuanced decision, George Wei J allowed the Plaintiff’s appeal in part while dismissing the Defendant’s cross-appeal. The Court affirmed that while pre-action disclosure is not a license for "fishing expeditions," it serves a vital role in allowing a potential litigant to determine if a "viable" or "good" cause of action exists. However, the Court maintained a protective stance over the identity of media sources at the pre-action stage, ruling that the Plaintiff did not require the specific names of the sources to assess the merits of a malicious falsehood claim against the publisher. Instead, the Court ordered the disclosure of redacted communications that would allow the Plaintiff to scrutinize the "due diligence" and "reliability" of the sources claimed by the Defendant, without prematurely stripping the Defendant of its journalistic confidentiality.

This decision is a landmark for practitioners as it clarifies that the "newspaper rule"—a traditional protection against disclosing sources in libel and slander actions—does not operate as an absolute privilege in Singapore but rather as a factor within the court’s broader discretion. The judgment emphasizes that the necessity of disclosure must be weighed against the potential for oppression and the public interest in the free flow of information. By ordering targeted, redacted discovery, the Court struck a balance that facilitates the administration of justice while respecting the operational realities of the media industry.

Timeline of Events

1. 20 December 2015: Ms. Bhawna Gupta, a correspondent for the Defendant, emailed the Plaintiff’s Chief Financial Officer, Mr. Jayesh Shah, seeking comments on a rumored acquisition by SPI.
2. 21 December 2015 (Morning): Mr. Shah replied to the email, stating the report was "completely base less" and that the Plaintiff "fully deny it."
3. 21 December 2015 (Later): The Defendant published the Article titled "Exclusive: Sun Pharma in early talks to acquire Intas Pharmaceuticals in $2b+ deal" on its website.
4. 24 December 2015: Following a complaint from the Plaintiff’s Vice Chairman, Mr. Binish Chudgar, the Defendant published an "Editor’s Note" on its website, maintaining that the story was based on "reliable sources" and "standard protocol."
5. 30 December 2015: The Plaintiff’s Indian counsel sent a demand letter to the Defendant, describing the article as "false, baseless and malicious" and demanding the identity of the sources.
6. 10 March 2016: The Defendant’s director and editor-in-chief, Mr. Thomas Philip Joji, responded to the Plaintiff, asserting that due diligence had been conducted and refusing to disclose sources.
7. 18 March 2016: The Plaintiff’s Singapore solicitors sent a further letter of demand, indicating an intention to commence proceedings for malicious falsehood and requesting pre-action disclosure.
8. 21 July 2016: The Plaintiff filed Originating Summons 734 of 2016 seeking pre-action discovery and interrogatories.
9. 26 September 2016: The Assistant Registrar (AR) heard the application and granted partial discovery of redacted documents but denied the request for interrogatories.
10. 10 February 2017: The High Court heard the cross-appeals (RA 362/2016 and RA 378/2016) against the AR’s decision.
11. 10 April 2017: George Wei J delivered the judgment, allowing the Plaintiff’s appeal in part and dismissing the Defendant’s appeal.

What Were the Facts of This Case?

The Plaintiff, Intas Pharmaceuticals Limited ("Intas"), is a prominent Indian company involved in the manufacturing and distribution of pharmaceutical products. The Defendant, DealStreetAsia Pte Ltd, is a Singapore-incorporated entity that operates a financial news website focusing on private equity, venture capital, and corporate deals across Asia. The conflict centered on a news report published by the Defendant on 21 December 2015, which claimed that Sun Pharmaceuticals Industries Ltd ("SPI"), a major competitor of the Plaintiff, was in "early talks" to acquire the Plaintiff’s business for approximately $2.3 billion.

The Article, authored by Ms. Bhawna Gupta, cited "multiple sources familiar with the development" and "executive(s) who [are] directly aware of the development." It further alleged that SPI had engaged an "unnamed global advisory firm" to conduct due diligence on the Plaintiff. Crucially, the Article was published despite a direct and timely denial from the Plaintiff’s CFO, Mr. Jayesh Shah, who had informed Ms. Gupta via email on the morning of the publication that the rumors were entirely baseless. The Plaintiff contended that the publication of such a significant and false claim caused immediate and substantial harm to its business reputation and commercial interests.

Following the publication, the Plaintiff’s Vice Chairman, Mr. Binish Chudgar, contacted the Defendant to demand an apology and a retraction. In response, the Defendant published an "Editor’s Note" on 24 December 2015. This note did not retract the story but instead sought to clarify that the Plaintiff’s denial had been included in the original report. The note reiterated that the Defendant stood by its "reliable sources" and that the story was published after following "all standard protocol." The Defendant’s refusal to provide details regarding these sources or the nature of the "due diligence" performed led the Plaintiff to suspect that the sources were either non-existent or had acted with malice.

The Plaintiff’s primary legal concern was the tort of malicious falsehood. To succeed in such a claim, a plaintiff must prove that: (a) the defendant published a false statement about the plaintiff; (b) the statement was published maliciously; and (c) the plaintiff suffered special damage (subject to statutory exceptions). The Plaintiff argued that it could not properly assess the "malice" element without knowing what the sources actually told the Defendant and whether the Defendant had any reasonable basis to believe those sources were reliable. Furthermore, the Plaintiff sought to identify the sources to determine if they were disgruntled employees or competitors who could be sued directly for providing false information.

In the proceedings below, the Assistant Registrar had ordered the Defendant to produce documents and correspondence evidencing the statements made in the Article and the Editor’s Note, including communications with the alleged sources and the global advisory firm. However, the AR allowed the Defendant to redact any information that would identify the sources. The AR also dismissed the Plaintiff’s application for pre-action interrogatories, which sought to compel the Defendant to answer specific questions about the identity and location of the sources. Both parties were dissatisfied with this outcome: the Plaintiff wanted the identities and the interrogatories, while the Defendant argued that no discovery should have been ordered at all, characterizing the application as a "fishing expedition" intended to unmask confidential journalistic sources.

What Were the Key Legal Issues?

The High Court identified several critical legal issues that required resolution to determine the extent of pre-action disclosure:

• The Threshold for Pre-action Disclosure: Whether the Plaintiff had demonstrated that the disclosure was "necessary" and "just" under Order 24 Rule 6 (discovery) and Order 26A Rule 1 (interrogatories) of the Rules of Court. This involved an analysis of whether the Plaintiff had a "viable" cause of action and whether the information sought was essential to "fashion" the pleadings.
• The "First Purpose" vs. The "Second Purpose": The Court distinguished between seeking disclosure to assess a claim against the Defendant (the publisher) and seeking disclosure to identify third-party wrongdoers (the sources). The latter purpose invoked the Norwich Pharmacal doctrine.
• Materiality of Source Identity: Whether the actual names and identities of the sources were material to the Plaintiff’s potential claim for malicious falsehood against the Defendant at the pre-action stage.
• The "Newspaper Rule" and Confidentiality: To what extent the court should protect the confidentiality of journalistic sources in the context of a pre-action application, and whether the "newspaper rule" applied in Singapore to prevent disclosure before the trial stage.
• The Appropriateness of Interrogatories: Whether pre-action interrogatories were necessary in addition to documentary discovery, particularly where the Plaintiff alleged that some communications might have been oral.

How Did the Court Analyse the Issues?

George Wei J began the analysis by emphasizing the foundational principles of pre-action disclosure in Singapore. Citing the Court of Appeal in Dorsey James Michael v World Sport Group Pte Ltd [2014] 2 SLR 208, the Court noted that the primary objective is to enable a potential plaintiff to "find out whether he has a cause of action" and to "avoid the unnecessary commencement of legal proceedings." However, this must be balanced against the need to prevent the process from being used for "fishing" (referencing Kuah Kok Kim v Ernst & Young [1996] 3 SLR(R) 485).

Regarding the "First Purpose" (the claim against the Defendant), the Court examined the elements of malicious falsehood. The Court noted that while the Plaintiff had a "viable" claim in the sense that the Article was published and denied, the element of "malice" was difficult to evaluate without knowing the basis of the Defendant’s "due diligence." The Court held:

"The controlling requirements for both types of pre-action disclosure are that the court must be satisfied that it is necessary (see O 26A r 2 and O 24 r 7) and just (see O 26A r 1(5) and O 24 r 6(5)) to order such disclosure." (at [27])

The Court found that the Defendant’s own public assertions in the Article and Editor’s Note—specifically that it relied on "multiple sources," "executives directly aware," and "standard protocol"—made the communications with those sources highly relevant. If the Defendant claimed to have "reliable sources," the Plaintiff was entitled to see the content of those communications to determine if the Defendant’s reliance was indeed reasonable or if it was a reckless fabrication. However, the Court agreed with the AR that the identity of the sources was not strictly necessary at this stage to assess the Defendant’s malice. The "malice" inquiry focuses on the Defendant’s state of mind, which can be gauged from the nature of the information received and the steps taken to verify it, regardless of the source's name.

Regarding the "Second Purpose" (identifying the sources), the Court applied the Norwich Pharmacal test. This requires the Plaintiff to show that the Defendant was "mixed up" in the tortious acts of the sources and that disclosure of their identities is necessary to bring an action against them. The Court observed that while the Plaintiff suspected the sources might be liable for malicious falsehood or breach of confidentiality, there was insufficient evidence at the pre-action stage to justify the "exceptional" step of unmasking anonymous sources. The Court highlighted that the Plaintiff’s primary grievance appeared to be with the Defendant’s publication itself.

The Court then addressed the "Newspaper Rule." The Defendant argued, based on KLW Holdings v Singapore Press Holdings Ltd [2002] 2 SLR(R) 477, that there is a long-standing practice of not compelling newspapers to disclose sources before trial. George Wei J, however, preferred the view in Odex Pte Ltd v Pacific Internet Ltd [2008] 3 SLR(R) 18, which suggested that the "newspaper rule" is not an absolute privilege but a factor in the court's discretion. The Court stated:

"In my view, the 'newspaper rule' is not a rule of law but a rule of practice which the court may take into account in exercising its discretion... the court must balance the interest of the plaintiff in obtaining the information against the public interest in protecting the confidentiality of journalistic sources." (at [63]-[65])

On the issue of Interrogatories, the Court was less inclined to grant relief. The Plaintiff argued that interrogatories were necessary because the Defendant might have received information through oral conversations not captured in documents. George Wei J held that pre-action interrogatories are a "more intrusive" tool and should be used sparingly. Since the Defendant had already been ordered to produce documents (including notes of meetings or calls), the Court found that the Plaintiff had not demonstrated the necessity of interrogatories at the pre-action stage. The Court noted that if a suit were eventually filed, the Plaintiff could seek interrogatories during the normal course of discovery.

Finally, the Court refined the categories of documents to be disclosed. It expanded the AR’s order to include documents evidencing the "reactions and comments" the Defendant claimed to have sought from SPI and the global advisory firm. This was deemed necessary because the Defendant had used these claims to bolster the credibility of the Article in its Editor’s Note. By ordering these documents (subject to redaction of identities), the Court ensured the Plaintiff could test the veracity of the Defendant’s "due diligence" defense.

What Was the Outcome?

The High Court dismissed the Defendant’s appeal (RA 378/2016) and allowed the Plaintiff’s appeal (RA 362/2016) in part. The operative order of the Court was as follows:

"For the reasons above, the Defendant’s appeal is dismissed and the Plaintiff’s appeal is allowed in part." (at [73])

The Court ordered the Defendant to provide pre-action discovery of the following categories of documents, subject to the redaction of any information (such as names, addresses, or descriptions) that would identify the sources:

• Documents and correspondence evidencing the statements in the Article that "multiple sources familiar with the development" and "executive(s) who [are] directly aware of the development" had told the Defendant about the acquisition talks.
• Documents evidencing the statement that a "global advisory firm" had been engaged by SPI.
• Documents evidencing the "reactions and comments" sought by the Defendant from SPI and the advisory firm, as mentioned in the Editor’s Note.
• Documents evidencing the "due diligence" and "standard protocol" the Defendant claimed to have followed.

The Court upheld the AR’s decision to refuse the Plaintiff’s application for pre-action interrogatories and the request for the unredacted identities of the sources. The Court also ordered that the costs of the appeals be taxed if not agreed between the parties. The Plaintiff was granted the right to use the disclosed documents solely for the purpose of the intended proceedings, subject to the usual implied undertakings (the Riddick undertaking).

Why Does This Case Matter?

This case is of paramount importance for practitioners dealing with media law and pre-action procedure in Singapore. It provides a clear framework for how the courts will handle the tension between the right to seek redress for commercial disparagement and the media's need to protect confidential sources. The judgment reinforces that Singapore does not recognize an absolute "journalist privilege," but it does afford significant weight to the public interest in the free flow of information when exercising discretionary powers under the Rules of Court.

For litigators, the decision clarifies the "necessity" test for pre-action discovery. George Wei J’s reasoning suggests that "necessity" is not an absolute bar but a relative one: is the information necessary to fairly assess the claim? By allowing redacted discovery, the Court showed that a plaintiff can often evaluate the "malice" or "recklessness" of a publisher without knowing the specific names of the sources. This "middle path" prevents the pre-action stage from becoming a tool for collateral purposes, such as identifying whistleblowers or confidential informants, while still providing the plaintiff with the "ammunition" needed to decide whether to sue the publisher.

The case also highlights the limitations of Norwich Pharmacal relief in the media context. The Court’s reluctance to order the disclosure of source identities at the pre-action stage suggests that plaintiffs must meet a very high evidentiary burden to show that the identity itself is the "missing link" required for justice. Practitioners should note that simply alleging a potential claim against the sources is unlikely to be enough; there must be a compelling reason why the claim against the publisher is insufficient or why the sources' identities are essential to the primary cause of action.

Furthermore, the judgment serves as a warning to media organizations. By ordering discovery of documents related to "due diligence" and "standard protocols," the Court signaled that news outlets cannot insulate themselves from discovery simply by asserting they have "reliable sources." If a publisher makes public claims about the robustness of its verification process, those claims can be tested through pre-action discovery. This encourages greater accountability in financial journalism and ensures that the "newspaper rule" is not used as a shield for shoddy or malicious reporting.

Finally, the decision touches upon the jurisdictional aspects of internet publication. The Court noted that for the purpose of malicious falsehood, the statement is "published" where it is accessed by the end user. This confirms that Singapore courts will take jurisdiction over foreign-authored content if it is targeted at or accessed by a significant audience in Singapore, provided the other elements of the tort are met. This is particularly relevant in the age of global digital news platforms like DealStreetAsia.

Practice Pointers

• Specificity in Categories: When drafting an application for pre-action discovery, practitioners should tie each requested category of documents directly to an element of the intended cause of action (e.g., "malice" in malicious falsehood).
• The Redaction Compromise: If the primary goal is to assess a claim against a publisher, be prepared to accept redacted documents. Courts are far more likely to grant discovery of the substance of communications than the identity of the sources.
• Exhaust Pre-action Correspondence: The Court closely examined the exchange of letters between Intas and DealStreetAsia. A clear, detailed demand letter that identifies the alleged falsehoods is essential to demonstrating that the subsequent application is not a "fishing expedition."
• Interrogatories as a Last Resort: Avoid seeking pre-action interrogatories unless it can be proven that documentary discovery will be fundamentally inadequate. The "intrusive" nature of interrogatories makes them a difficult sell at the pre-action stage.
• Address the "Newspaper Rule" Proactively: If representing a plaintiff against a media defendant, argue that the "newspaper rule" is a matter of discretion, not an absolute privilege, and emphasize the specific need for the information to achieve justice.
• Mind the Riddick Undertaking: Remember that any documents obtained through pre-action discovery are subject to an implied undertaking that they will not be used for any purpose other than the specific intended proceedings.
• Statutory Exceptions: When pleading malicious falsehood, consider whether s 6(1) of the Defamation Act applies, which may obviate the need to prove special damage in certain circumstances.

Subsequent Treatment

The decision in Intas Pharmaceuticals Ltd v DealStreetAsia Pte Ltd has been recognized as a key authority on the application of the "necessity" and "justice" tests in pre-action disclosure. It is frequently cited for the proposition that the court must balance the applicant's need to assess a potential claim against the respondent's interest in confidentiality. The "middle path" of redacted discovery established by George Wei J continues to serve as a model for resolving disputes involving confidential commercial or journalistic information at the pre-action stage. [None recorded in extracted metadata regarding specific subsequent overruling or negative treatment].

Legislation Referenced

• Supreme Court of Judicature Act (Cap 322, 2007 Rev Ed), First Schedule, Para 12
• Prevention of Corruption Act (Cap 241, 1993 Rev Ed), s 36
• Defamation Act (Cap 75, 2014 Rev Ed), s 6(1)
• Rules of Court (Cap 322, R 5, 2014 Rev Ed), Order 24 Rule 6; Order 24 Rule 7; Order 26A Rule 1; Order 18 Rule 12; Order 78 Rule 3

Cases Cited

• Applied / Followed:
  • Dorsey James Michael v World Sport Group Pte Ltd [2014] 2 SLR 208
  • Kuah Kok Kim v Ernst & Young [1996] 3 SLR(R) 485
  • Ching Mun Fong v Standard Chartered Bank [2012] 4 SLR 185
  • Odex Pte Ltd v Pacific Internet Ltd [2008] 3 SLR(R) 18
• Considered / Referred to:
  • Norwich Pharmacal Co v Customs and Excise Commissioners [1974] AC 133
  • KLW Holdings v Singapore Press Holdings Ltd [2002] 2 SLR(R) 477
  • Haywood Management Ltd v Eagle Aero Technology Pte Ltd [2014] 4 SLR 478
  • Success Elegant Trading Ltd v La Dolce Vita Fine Dining Co Ltd [2016] 4 SLR 1392
  • Ng Koo Kay Benedict v Zim Integrated Shipping Services Ltd [2010] 2 SLR 860
  • Beckkett Pte Ltd v Deutsche Bank AG [2005] 3 SLR(R) 555
  • Relfo Ltd (in liquidation) v Bhimji Velji Jadva Varsani [2009] 4 SLR(R) 351
  • Spiliada Maritime Corp v Cansulex Ltd [1987] AC 46
  • Riddick v Thames Board Mills Ltd [1977] QB 881
  • Dow Jones and Company Inc v Gutnick (2002) 210 CLR 575
  • Nirumalan K Pillay and others v A Balakrishnan and others [1996] 2 SLR(R) 650
  • WBG Network (Singapore) Pte Ltd v Meridian Life International Pte Ltd [2008] 4 SLR(R) 727

Source Documents

• Original judgment PDF: Download (PDF, hosted on Legal Wires CDN)
• Official eLitigation record: View on elitigation.sg